Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: limitations and prospects: a systematic review

Overview of attention for article published in Cell Communication and Signaling, November 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

So far, Altmetric has seen 6 tweets from 5 users, with an upper bound of 26,624 followers.

Immune checkpoint inhibitors have proven useful in treating many cancers. Unfortunately, #PancreaticCancer is not one of them. A recent @BioMedCentral review explored potential approaches for tackling this problem: https://t.co/wrtkRKzS7E #cancer #immunoth

Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: limitations and prospects: a systematic review https://t.co/QsJPZ1zxkz

RT @Aenoreth: Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: limitations and prospects: a systematic review https://t.c…

Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: limitations and prospects: a systematic review https://t.co/QsJPZ1zxkz

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 2 additional tweets.